Parametric Modeling of Survival Data Based on Human Immune Virus (HIV) Infected Adult Patients under Highly Active Antiretroviral Therapy (HAART) : a Case of Zewditu Referral Hospital, Addis Ababa (AA) , Ethiopia
Sharma, M.; Legesse, H.
International Journal of Statistics in Medical Research 5(4): 240-247
2016
ISSN/ISBN: 1929-6029 Document Number: 642334
Document emailed within 1 workday
Related Documents
Kassa, A.; Teka, A.; Shewaamare, A.; Jerene, D. 2012: Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia Transactions of the Royal Society of Tropical Medicine and Hygiene 106(6): 363-370Breuckmann, F.; Neumann, T.; Kondratieva, J.; Wieneke, H.; Ross, B.; Nassenstein, K.; Barkhausen, J.; Kreuter, A.; Brockmeyer, N.; Erbel, R. 2005: Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART) European Journal of Medical Research 10(9): 395-399
Muhula, S.O.; Peter, M.; Sibhatu, B.; Meshack, N.; Lennie, K. 2015: Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya Pan African Medical Journal 20: 63
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Shiferaw, A.; Baye, A.M.; Amogne, W.; Feyissa, M. 2020: Herbal Medicine use and Determinant Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia Hiv/Aids 12: 941-949
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
Guo, F.-p.; Yu, X.-b.; Luo, L.; Han, Y.; Qiu, Z.-f.; Zuo, L.-y.; Li, Y.-l.; Yu, W.; Li, T.-s. 2010: The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients Zhonghua Nei Ke Za Zhi 49(8): 649-652
Tadesse, A.Worku.; Berhane Tsehay, Y.; Girma Belaineh, B.; Alemu, Y.Baheretibeb. 2012: Behavioral and emotional problems among children aged 6-14 years on highly active antiretroviral therapy in Addis Ababa: a cross-sectional study Aids Care 24(11): 1359-1367
Adane, A.; Desta, K.; Bezabih, A.; Gashaye, A.; Kassa, D. 2012: HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik Ii Hospital, Addis Ababa, Ethiopia Ethiopian Medical Journal 50(1): 13-21
Leng, L.K.; Pancharoen, C.; Bunupuradah, T.; Thisyakorn, U.; Trinavarat, P.; Sosothikul, D.; Ananworanich, J. 2007: Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease Journal of the Medical Association of Thailand 90(9): 1937-1942
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Chitra, P.; Bakthavatsalam, B.; Palvannan, T. 2011: Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1151-1154
De Beaudrap, P.; Etard, J.-F.ço.; Diouf, A.; Ndiaye, I.; Guèye, N.èy.F.; Guèye, P.M.é; Sow, P.S.; Mboup, S.; Ndoye, I.; Ecochard, R.é; Eric, D.; Ndoye, I.; Delaporte, E.; Etard, J.F.; Laurent, C.; Taverne, B.; Thierry-Mieg, M.; Bitèye, M.M.; Dieng, A.B.; Diouf, A.; Sarr, A.; Zié, L.; Cilote, V.; Lanièce, I.; Ndiaye, I.; Ndir, A.; Ndour, C.T.; Senghor, C.S.; Sow, P.S.; Basty Fall, M.; Dia Badiane, N.M.; Diakhaté, N.; Diallo, M.; Diouf, L.M.; Ngom Guèye, N.F.; Ba Fall, K.; Guèye, P.M.; Périno, C.; Diaw, P.A.; Diop Ndiaye, H.; Mboup, S.; Touré Kane, N.C.; Sow, K.; Diop, K.; Ndiaye, B.; Ciss, M.; Desclaux, A. 2009: Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal American Journal of Tropical Medicine and Hygiene 80(6): 1047-1053
Melo, L.Santos.Wolmer.de.; Lacerda, H.Ramos.; Campelo, E.; Moraes, E.; Ximenes, R.Arraes.de.Alencar. 2008: Survival of AIDS patients and characteristics of those who died over eight years of highly active antiretroviral therapy, at a referral center in northeast Brazil Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 12(4): 269-277
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Vibhagool, A.; Sungkanuparph, S.; Mootsikapun, P.; Chetchotisakd, P.; Tansuphaswaswadikul, S.; Bowonwatanuwong, C.; Ingsathit, A. 2003: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 36(10): 1329-1331